Human hepatitis B immunoglobulin (Guangdong Danxia Biopharm)
人免疫球蛋白（广东丹霞生物）
Report date: 2022/02/21 14:39:07
Base Information
Drug NameHuman hepatitis B immunoglobulin (Guangdong Danxia Biopharm)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2012/10/30
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A